Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002064468 | SCV002360894 | likely benign | Hypertrophic cardiomyopathy 14 | 2023-03-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434074 | SCV002745419 | likely benign | Cardiovascular phenotype | 2020-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004705806 | SCV005211378 | likely benign | not provided | criteria provided, single submitter | not provided |